By Ron Connolly, Senior Business Advisor, Adare Pharma Solutions
Are you searching for ways to accelerate first-in-human and dose escalation studies? Do you believe you are wasting R&D resources at earlier stages of development by making customized dosage forms for a specific clinical study that may never be used for a commercial product? Are you trying to formulate combination products with known chemical interactions?
Adare Pharma Solutions can increase the likelihood of leveraging the practical knowledge gained during early formulation efforts in later stages of development.
Using our innovative capsule-filling equipment and processing technology, as well as mini-tablet and drug-layered beadlet manufacturing capabilities, we can provide an adaptable, easily modified formulation even before knowing the therapeutic dose of your investigational new drug.